John Jett, Ph.D. acts as the Head of Clinical Development at NeuroNOS along with being the Head of Research and Clinical Development at Beyond Air. Dr. Jett brings more than 15 years of experience in the biotech industry across a wide range of therapeutic areas. Previously, Dr. Jett served as the Director of Clinical Development at Dermavant Sciences where he was the scientific director of an international phase 3 dermatology program. Prior to joining Dermavant Sciences, Dr. Jett held roles of increasing responsibility in the clinical development and translational medicine space at Roivant Sciences, Viamet Pharmaceuticals, and Targacept. His roles have included leading teams in clinical pharmacology, clinical and nonclinical development, clinical operations, biostatistics, and regulatory affairs, including development of two medicines currently on the market and numerous regulatory submissions in the U.S. and Europe.

Dr. Jett holds a Ph.D. in Pharmaceutical and Pharmacological Sciences from West Virginia University and a BS in Biology from Radford University. Prior to obtaining his Ph.D., Dr. Jett began his career in quality control at Cargill.